Showing results (691-700 of 1,579) with videos related to

Sort By:
Pageof 158
Biophysical Journal|April 1, 1994
Studies of the thermotropic phase behavior of phosphatidylcholines containing 2-alkyl substituted fatty acyl chains: a new class of phosphatidylcholines forming inverted nonlamellar phasesR N Lewis, R N McElhaney, P E Harper, et al.
Poultry Science|November 1, 1987
Critical vitamin supplementation of broiler diets high in alfalfa juice proteinV K Tsiagbe, R J Straub, M E Cook, et al.
The Journal of Nutrition|November 1, 1987
Identification of volatile sulfur derivatives released from feathers of chicks fed diets with various levels of sulfur-containing amino acidsV K Tsiagbe, R J Kraus, N J Benevenga, et al.
Medgenmed : Medscape General Medicine|April 20, 2002
Gastrointestinal medications and procedures in osteoarthritis patients treated with rofecoxib compared with nonselective NSAIDsD J Watson, S E Harper, P L Zhao, et al.
Clinical and Experimental Rheumatology|July 1, 1983
Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue diseaseH R Maricq, F E Harper, M M Khan, et al.
Journal of Environmental Management|March 3, 2019
Assessing public support for restrictions on transport of invasive wild pigs (Sus scrofa) in the United StatesMeredith J Grady, Erin E Harper, Keith M Carlisle, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 17, 2020
Vitamin E Promotes the Inverse Hexagonal Phase via a Novel Mechanism: Implications for Antioxidant RolePaul E Harper, Andres T Cavazos, Jacob J Kinnun, et al.
The American Journal of Medicine|June 1, 1982
A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year reportF E Harper, H R Maricq, R E Turner, et al.
Annals of the New York Academy of Sciences|February 11, 2000
Does the oxidative/glycolytic ratio determine proliferation or death in immune recognition?M K Newell, M E Harper, K Fortner, et al.
Clinical Therapeutics|August 25, 2001
Economic evaluation of rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritisJ M Pellissier, W L Straus, D J Watson, et al.
Pageof 158